biotech · Dystrophic Epidermolysis Bullosa · Autosomal Recessive Ichthyosis · KRYS
Krystal Biotech Netherlands
Krystal Biotech Netherlands B.V.
Krystal Biotech Netherlands patent portfolio — 14 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
Company details
- Status
- Public
- HQ
- 2100 Wharton Street, Suite 701, Pittsburgh, PA 15203, US
- Founded
- 2016
- Employees
- 306
- Programs
- 14
- Drugs
- 7
- Patents
- 14
Krystal Biotech Netherlands patents
14 pharmaceutical patents indexed for Krystal Biotech Netherlands. 0 expire within 24 months.
Krystal Biotech Netherlands has 14 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.
Patent portfolio
-
US 12364775
Viral vectors for cancer therapy
granted -
US 12128122
Recombinant nucleic acids encoding cosmetic protein(s) for aesthetic
granted -
US 11918660
Viral vectors for cancer therapy
granted -
US 11865148
Methods of delivering transgenes to the eye
granted -
US 11779660
Viral vectors for cancer therapy
granted -
US 11717547
Compositions and methods for the treatment of autosomal recessive congenital ichthyosis
granted -
US 11642384
Compositions and methods for the treatment of Netherton Syndrome
granted -
US 11185564
Compositions and methods for the treatment of wounds, disorders, and diseases of the skin
granted -
US 10829529
Compositions and methods for delivering CFTR polypeptides
granted -
US 10786438
Recombinant nucleic acids encoding cosmetic protein(s) for aesthetic applications
granted -
US 10525090
Compositions and methods for the treatment of autosomal recessive congenital ichthyosis
granted -
US 10441614
Compositions and methods for the treatment of wounds, disorders, and diseases of the skin
granted -
US 10155016
Compositions and methods for the treatment of wounds, disorders, and diseases of the skin
granted -
US 9877990
Compositions and methods for the treatment of wounds, disorders, and diseases of the skin
granted
Frequently asked questions
How many patents does Krystal Biotech Netherlands have?
14 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do Krystal Biotech Netherlands patents expire?
0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.